Welcome to our dedicated page for HEALTHSTREAM SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHSTREAM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHSTREAM's regulatory disclosures and financial reporting.
HealthStream director Frank Gordon reported routine equity compensation activity. On June 8, 2026, he acquired 3,148 shares of common stock through the vesting of restricted share units, a non-cash transaction recorded with code M for derivative exercise/conversion.
Following this vesting, Gordon directly holds 215,552 shares of HealthStream common stock. He also reports several indirect holdings, including shares held in a family trust, custodial accounts for minor children, and entities such as The Joel Company and Crofton Capital, reflecting ownership through related accounts rather than new market trades.
The footnotes explain that each restricted share unit represents the right to receive one share of common stock upon vesting and that these RSUs vest over a three year vesting schedule, contingent on continued service. The filing shows no open‑market purchases or sales, only the conversion of RSUs into common stock and updated indirect ownership positions.
HealthStream Inc. director Linda Rebrovick reported an open-market sale of company stock. On June 1, 2026, she sold 2,000 shares of HealthStream common stock at $25.00 per share.
After this transaction, she directly holds 54,181 shares of HealthStream common stock. The filing notes that the sale was made under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025.
HSTM submitted a Form 144 notice for the proposed sale of common stock. The filing lists a proposed sale by Linda Rebrovick of 2,000 shares dated 05/28/2026 with an amount shown as $50,000.00. The excerpt also lists stock awards dated 09/10/2021 (188 shares), 03/24/2014 (1,149 shares) and 04/26/2016 (663 shares), and names UBS Financial Services, Inc. as the broker.
Taylor Tate Deborah reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc. director Deborah Taylor Tate reported a compensation-related equity grant. She received 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock when the units vest. The RSUs follow a three-year vesting schedule, vesting in three equal annual installments beginning May 28, 2027, contingent on continued service. Following these transactions, she directly holds 21,551 shares of common stock, and 3,654 RSUs linked to an equivalent number of underlying common shares.
RAPPUHN TERRY ALLISON reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc director Terry Allison Rappuhn reported a new equity award and her current shareholdings. She received 3,654 restricted share units (RSUs), each representing the contingent right to one share of common stock when the units vest.
The RSUs are subject to a three-year vesting schedule and vest annually in three equal installments beginning May 28, 2027, contingent on continued service. Following the reported transactions, she directly holds 7,243 shares of common stock and the 3,654 RSUs, reflecting a routine compensation-related grant rather than an open-market trade.
REBROVICK LINDA reported acquisition or exercise transactions in this Form 4 filing.
HEALTHSTREAM INC director Linda Rebrovick reported an equity award and updated holdings. She received a grant of 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock upon vesting. The RSUs vest over three years in three equal annual installments starting on May 28, 2027, contingent on continued service. Following this update, she holds 56,181 shares of common stock directly and 3,654 RSUs as a separate derivative position.
MCLAREN JEFFREY L reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc. director Jeffrey L. McLaren received a new equity award in the form of restricted share units. He was granted 3,654 RSUs, each representing the contingent right to receive one share of common stock upon vesting.
The RSUs are subject to a three-year vesting schedule, vesting annually in three equal installments beginning on May 28, 2027, contingent on continued service. Following this award, McLaren is reported as holding 22,600 shares of common stock directly, alongside the 3,654 RSUs.
Jahangir Amir Alex reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc director Amir Alex Jahangir reported a new equity award and his current holdings. He received 3,654 restricted share units (RSUs), each representing the contingent right to one share of common stock upon vesting. The RSUs follow a three-year vesting schedule, vesting in three equal annual installments beginning on May 28, 2027, contingent on continued service at the time of vesting. Following these transactions, he directly holds 3,257 shares of common stock and 3,654 RSUs linked to common stock.
DENT THOMPSON reported acquisition or exercise transactions in this Form 4 filing.
HEALTHSTREAM INC director Dent Thompson reported a new equity award. On May 28, 2026, he received 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock when the units vest.
The RSUs vest over three years in equal annual installments beginning May 28, 2027, and are contingent on his continued service. Following this filing, Thompson holds 136,827 shares of common stock directly, in addition to the 3,654 RSUs.
Beard Charles Jr. reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc. director Charles Jr. Beard reported an equity compensation grant rather than a stock trade. On May 28, 2026, he received 3,654 restricted share units (RSUs), each representing the right to receive one share of HealthStream common stock when it vests.
The RSUs follow a three-year vesting schedule, vesting in three equal annual installments beginning May 28, 2027, and require continued service through each vesting date. This filing does not show any open-market purchases or sales, and Beard’s post-transaction direct RSU holding from this grant is 3,654 units.